[Efficacy of low-dose mifepristone in patients with thrombotic disorders complicated by heavy menstrual bleeding].

Objective: To evaluate the efficacy and safety of low-dose mifepristone (10-25 mg) in patients with thromboembolic disorders complicated by heavy menstrual bleeding (HMB). Methods: The data of 13 patients (median age:37 years) with thrombotic disorde…

Preview only. Read the full abstract at the source